The major adverse events were gastrointestinal adverse events, which were mostly mild to moderate [14, 34, 35]
HIMS acquires at-home lab device, YourBio but elects to not pursuit broad at-home testing
PBMs with access to patent expiration data can time formulary changes to shift patients to generics at the moment generic launch occurs, capturing the price reduction for their plan sponsor clients or alternatively, if rebates are sufficiently large, maintaining brand drug formulary preference even after generic entry, which has also been documented
Fatigue and mild dizziness may follow 2 to 5 days into treatment
These factors may include the strength of the evidence, impact on the persons quality of life, and whether the injury is life-altering
Cutis 1992